GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Id4
|
ENSRNOG00000016099 | inhibitor of DNA binding 4, HLH protein |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Id4 | rn6_v1_chr17_-_16695126_16695126 | 0.34 | 4.2e-10 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_94130852 | 120.00 |
ENSRNOT00000011485
|
Mal2
|
mal, T-cell differentiation protein 2 |
chr1_-_54748763 | 103.80 |
ENSRNOT00000074549
|
LOC100911027
|
protein MAL2-like |
chr1_-_102106127 | 87.96 |
ENSRNOT00000028685
|
Kcnj11
|
potassium voltage-gated channel subfamily J member 11 |
chr15_+_37806836 | 68.16 |
ENSRNOT00000076285
|
Il17d
|
interleukin 17D |
chr1_-_80331626 | 65.88 |
ENSRNOT00000022577
|
AABR07002677.1
|
|
chr9_-_80166807 | 62.79 |
ENSRNOT00000079493
|
Igfbp5
|
insulin-like growth factor binding protein 5 |
chr14_-_80169431 | 61.51 |
ENSRNOT00000079769
ENSRNOT00000058315 |
Ablim2
|
actin binding LIM protein family, member 2 |
chr5_+_151692108 | 60.58 |
ENSRNOT00000086144
|
Fam46b
|
family with sequence similarity 46, member B |
chr10_+_47281786 | 59.70 |
ENSRNOT00000089123
|
Kcnj12
|
potassium voltage-gated channel subfamily J member 12 |
chr8_-_130429132 | 57.09 |
ENSRNOT00000026261
|
Hhatl
|
hedgehog acyltransferase-like |
chr9_-_9985630 | 56.33 |
ENSRNOT00000071780
|
Crb3
|
crumbs 3, cell polarity complex component |
chr12_+_30450316 | 55.26 |
ENSRNOT00000001222
|
Phkg1
|
phosphorylase kinase, gamma 1 |
chr8_-_116361343 | 55.04 |
ENSRNOT00000066296
|
Sema3b
|
semaphorin 3B |
chr10_+_77537340 | 54.70 |
ENSRNOT00000003297
|
Tmem100
|
transmembrane protein 100 |
chr10_+_40247436 | 53.74 |
ENSRNOT00000079830
|
Gpx3
|
glutathione peroxidase 3 |
chr1_+_199449973 | 52.57 |
ENSRNOT00000029994
|
Trim72
|
tripartite motif containing 72 |
chr11_-_88972176 | 52.34 |
ENSRNOT00000002498
|
Pkp2
|
plakophilin 2 |
chr1_-_254735548 | 50.80 |
ENSRNOT00000025258
|
Ankrd1
|
ankyrin repeat domain 1 |
chr10_-_103919605 | 50.52 |
ENSRNOT00000004718
|
Hid1
|
HID1 domain containing |
chr16_-_49574314 | 49.83 |
ENSRNOT00000017568
ENSRNOT00000085535 ENSRNOT00000017054 |
Pdlim3
|
PDZ and LIM domain 3 |
chr16_-_81912738 | 49.80 |
ENSRNOT00000087095
|
Mcf2l
|
MCF.2 cell line derived transforming sequence-like |
chr11_+_27208564 | 49.17 |
ENSRNOT00000002158
|
Map3k7cl
|
MAP3K7 C-terminal like |
chr2_-_186245163 | 48.20 |
ENSRNOT00000089339
|
Dclk2
|
doublecortin-like kinase 2 |
chr8_+_57886168 | 47.90 |
ENSRNOT00000039336
|
Exph5
|
exophilin 5 |
chr2_+_242882306 | 47.78 |
ENSRNOT00000013661
|
Ddit4l
|
DNA-damage-inducible transcript 4-like |
chr1_-_100669684 | 47.67 |
ENSRNOT00000091760
|
Myh14
|
myosin heavy chain 14 |
chr9_-_88356716 | 47.59 |
ENSRNOT00000077503
|
Col4a4
|
collagen type IV alpha 4 chain |
chr15_+_34251606 | 47.58 |
ENSRNOT00000025725
|
Fitm1
|
fat storage-inducing transmembrane protein 1 |
chr8_-_72836159 | 46.81 |
ENSRNOT00000024617
|
Tpm1
|
tropomyosin 1, alpha |
chr2_-_24923128 | 46.70 |
ENSRNOT00000044087
|
Pde8b
|
phosphodiesterase 8B |
chr8_+_32018560 | 46.43 |
ENSRNOT00000007358
|
Adamts8
|
ADAM metallopeptidase with thrombospondin type 1 motif, 8 |
chr14_-_105055421 | 45.39 |
ENSRNOT00000008274
|
Lgalsl
|
galectin-like |
chr9_-_88357182 | 44.73 |
ENSRNOT00000041176
|
Col4a4
|
collagen type IV alpha 4 chain |
chr18_+_56193978 | 44.65 |
ENSRNOT00000041533
ENSRNOT00000080177 |
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha |
chr7_-_130120579 | 44.49 |
ENSRNOT00000044376
|
Mapk12
|
mitogen-activated protein kinase 12 |
chr3_-_46726946 | 44.37 |
ENSRNOT00000011030
ENSRNOT00000086576 |
Itgb6
|
integrin subunit beta 6 |
chr12_+_28381982 | 44.21 |
ENSRNOT00000076101
|
Wbscr17
|
Williams-Beuren syndrome chromosome region 17 |
chr1_-_226353611 | 43.84 |
ENSRNOT00000037624
|
Dagla
|
diacylglycerol lipase, alpha |
chr2_+_3400977 | 42.83 |
ENSRNOT00000093593
|
Mctp1
|
multiple C2 and transmembrane domain containing 1 |
chr11_-_59110562 | 42.83 |
ENSRNOT00000047907
ENSRNOT00000042024 |
Lsamp
|
limbic system-associated membrane protein |
chr17_-_80320681 | 42.07 |
ENSRNOT00000023637
|
C1ql3
|
complement C1q like 3 |
chr3_+_2625015 | 41.52 |
ENSRNOT00000018927
|
Npdc1
|
neural proliferation, differentiation and control, 1 |
chr2_-_231521052 | 41.11 |
ENSRNOT00000089534
ENSRNOT00000080470 ENSRNOT00000084756 |
Ank2
|
ankyrin 2 |
chr7_-_50278842 | 40.97 |
ENSRNOT00000088950
|
Syt1
|
synaptotagmin 1 |
chr16_-_18757918 | 40.75 |
ENSRNOT00000084172
|
Sftpd
|
surfactant protein D |
chr5_+_128501847 | 40.56 |
ENSRNOT00000010645
|
Rab3b
|
RAB3B, member RAS oncogene family |
chr16_+_81616604 | 40.24 |
ENSRNOT00000026392
ENSRNOT00000057740 |
Adprhl1
Grtp1
|
ADP-ribosylhydrolase like 1 growth hormone regulated TBC protein 1 |
chr10_+_58342393 | 39.30 |
ENSRNOT00000010358
|
Wscd1
|
WSC domain containing 1 |
chr5_-_156141537 | 38.85 |
ENSRNOT00000019004
|
Alpl
|
alkaline phosphatase, liver/bone/kidney |
chr14_-_112946204 | 38.69 |
ENSRNOT00000056813
|
LOC103690141
|
coiled-coil domain-containing protein 85A-like |
chr1_-_170397191 | 38.27 |
ENSRNOT00000090181
|
Apbb1
|
amyloid beta precursor protein binding family B member 1 |
chr1_-_72464492 | 38.13 |
ENSRNOT00000068550
|
Nat14
|
N-acetyltransferase 14 |
chr3_-_9037942 | 37.61 |
ENSRNOT00000036770
|
Ier5l
|
immediate early response 5-like |
chr9_+_99998275 | 37.49 |
ENSRNOT00000074395
|
Gpc1
|
glypican 1 |
chr7_-_120744602 | 36.91 |
ENSRNOT00000018564
|
Kcnj4
|
potassium voltage-gated channel subfamily J member 4 |
chr3_-_51054378 | 36.87 |
ENSRNOT00000089243
|
Grb14
|
growth factor receptor bound protein 14 |
chr5_+_164808323 | 36.63 |
ENSRNOT00000011005
|
Nppa
|
natriuretic peptide A |
chr17_-_27112820 | 36.25 |
ENSRNOT00000018359
|
Bmp6
|
bone morphogenetic protein 6 |
chr9_+_68414339 | 36.13 |
ENSRNOT00000040778
|
Pard3b
|
par-3 family cell polarity regulator beta |
chr3_-_161246351 | 35.92 |
ENSRNOT00000020348
|
Tnnc2
|
troponin C2, fast skeletal type |
chr15_-_108210826 | 35.55 |
ENSRNOT00000064705
|
Dock9
|
dedicator of cytokinesis 9 |
chr5_+_1417478 | 35.23 |
ENSRNOT00000008153
ENSRNOT00000085564 |
Jph1
|
junctophilin 1 |
chr4_+_144382945 | 35.23 |
ENSRNOT00000007601
|
Cav3
|
caveolin 3 |
chr4_-_14490446 | 35.09 |
ENSRNOT00000009132
|
Sema3c
|
semaphorin 3C |
chr1_+_220335254 | 34.92 |
ENSRNOT00000072261
|
Rin1
|
Ras and Rab interactor 1 |
chr19_-_10101451 | 34.23 |
ENSRNOT00000017629
|
Mmp15
|
matrix metallopeptidase 15 |
chr1_-_215846911 | 34.21 |
ENSRNOT00000089171
|
Igf2
|
insulin-like growth factor 2 |
chr12_+_943006 | 34.03 |
ENSRNOT00000001449
|
Kl
|
Klotho |
chr7_+_123043503 | 33.91 |
ENSRNOT00000026258
ENSRNOT00000086355 |
Tef
|
TEF, PAR bZIP transcription factor |
chr14_+_36047144 | 33.78 |
ENSRNOT00000003088
|
Lnx1
|
ligand of numb-protein X 1 |
chr2_-_172361779 | 33.70 |
ENSRNOT00000085876
|
Schip1
|
schwannomin interacting protein 1 |
chr8_+_39997875 | 33.55 |
ENSRNOT00000050609
|
Esam
|
endothelial cell adhesion molecule |
chr8_+_119030875 | 33.11 |
ENSRNOT00000028458
|
Myl3
|
myosin light chain 3 |
chr11_+_87058616 | 33.07 |
ENSRNOT00000002576
ENSRNOT00000082855 |
Prodh1
|
proline dehydrogenase 1 |
chr20_-_4823475 | 33.02 |
ENSRNOT00000082536
ENSRNOT00000001114 |
Atp6v1g2
|
ATPase H+ transporting V1 subunit G2 |
chr7_-_140356209 | 32.90 |
ENSRNOT00000077856
|
Rnd1
|
Rho family GTPase 1 |
chr1_+_220428481 | 32.78 |
ENSRNOT00000027335
|
LOC108348044
|
ras and Rab interactor 1 |
chr10_-_82887497 | 32.78 |
ENSRNOT00000005644
|
Itga3
|
integrin subunit alpha 3 |
chr1_-_213650247 | 32.75 |
ENSRNOT00000019679
|
Cox8b
|
cytochrome c oxidase, subunit VIIIb |
chr18_+_16650806 | 32.61 |
ENSRNOT00000093679
ENSRNOT00000041961 ENSRNOT00000093140 |
Fhod3
|
formin homology 2 domain containing 3 |
chr2_+_251634431 | 32.58 |
ENSRNOT00000045016
|
Ddah1
|
dimethylarginine dimethylaminohydrolase 1 |
chr7_+_58814805 | 32.56 |
ENSRNOT00000005909
|
Tspan8
|
tetraspanin 8 |
chr9_-_104350308 | 32.43 |
ENSRNOT00000033958
|
Slco4c1
|
solute carrier organic anion transporter family, member 4C1 |
chrX_-_68562873 | 32.37 |
ENSRNOT00000076193
|
Ophn1
|
oligophrenin 1 |
chrX_-_68563137 | 32.23 |
ENSRNOT00000034772
|
Ophn1
|
oligophrenin 1 |
chr13_-_42263024 | 32.03 |
ENSRNOT00000004741
|
Lypd1
|
Ly6/Plaur domain containing 1 |
chr1_+_201055644 | 31.86 |
ENSRNOT00000054937
ENSRNOT00000047161 |
Tacc2
|
transforming, acidic coiled-coil containing protein 2 |
chr9_-_85626094 | 31.73 |
ENSRNOT00000020919
|
Serpine2
|
serpin family E member 2 |
chr10_+_86303727 | 31.69 |
ENSRNOT00000037752
|
Ppp1r1b
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr9_+_88357556 | 30.73 |
ENSRNOT00000020669
|
Col4a3
|
collagen type IV alpha 3 chain |
chrX_+_157150655 | 30.26 |
ENSRNOT00000090795
|
Pnck
|
pregnancy up-regulated nonubiquitous CaM kinase |
chr10_-_20818128 | 30.16 |
ENSRNOT00000011061
|
Wwc1
|
WW and C2 domain containing 1 |
chr1_+_177093387 | 30.06 |
ENSRNOT00000021858
|
Mical2
|
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
chr3_-_175709465 | 29.54 |
ENSRNOT00000089971
|
Gata5
|
GATA binding protein 5 |
chr9_+_111028575 | 29.27 |
ENSRNOT00000043451
|
Pam
|
peptidylglycine alpha-amidating monooxygenase |
chr1_+_101682172 | 29.18 |
ENSRNOT00000028540
|
Car11
|
carbonic anhydrase 11 |
chr4_+_120133713 | 29.15 |
ENSRNOT00000017240
|
Gata2
|
GATA binding protein 2 |
chr7_+_11383116 | 29.08 |
ENSRNOT00000066348
|
Nmrk2
|
nicotinamide riboside kinase 2 |
chr9_+_111028824 | 28.76 |
ENSRNOT00000041418
ENSRNOT00000056457 |
Pam
|
peptidylglycine alpha-amidating monooxygenase |
chr12_-_5773036 | 28.63 |
ENSRNOT00000041365
|
Fry
|
FRY microtubule binding protein |
chr1_-_84150084 | 28.62 |
ENSRNOT00000028322
|
Ltbp4
|
latent transforming growth factor beta binding protein 4 |
chr8_+_130416355 | 28.50 |
ENSRNOT00000026234
|
Klhl40
|
kelch-like family member 40 |
chr14_-_43072843 | 28.08 |
ENSRNOT00000064263
|
Limch1
|
LIM and calponin homology domains 1 |
chr19_-_645937 | 28.07 |
ENSRNOT00000016521
|
Car7
|
carbonic anhydrase 7 |
chr6_+_137184820 | 28.07 |
ENSRNOT00000073796
|
Adssl1
|
adenylosuccinate synthase like 1 |
chr14_-_112946875 | 27.99 |
ENSRNOT00000081981
|
LOC103690141
|
coiled-coil domain-containing protein 85A-like |
chr3_+_58632476 | 27.94 |
ENSRNOT00000010630
|
Rapgef4
|
Rap guanine nucleotide exchange factor 4 |
chr1_+_215609036 | 27.89 |
ENSRNOT00000076187
|
Tnni2
|
troponin I2, fast skeletal type |
chr1_-_146556171 | 27.88 |
ENSRNOT00000017636
|
Arnt2
|
aryl hydrocarbon receptor nuclear translocator 2 |
chr15_-_13228607 | 27.81 |
ENSRNOT00000042010
ENSRNOT00000088214 |
Ptprg
|
protein tyrosine phosphatase, receptor type, G |
chr13_+_52662996 | 27.48 |
ENSRNOT00000047682
|
Tnnt2
|
troponin T2, cardiac type |
chr1_+_7252349 | 27.40 |
ENSRNOT00000030329
|
Plagl1
|
PLAG1 like zinc finger 1 |
chr9_+_82596355 | 27.36 |
ENSRNOT00000065076
|
Speg
|
SPEG complex locus |
chr9_+_82556573 | 27.32 |
ENSRNOT00000026860
|
Des
|
desmin |
chr5_+_158090173 | 27.27 |
ENSRNOT00000088766
ENSRNOT00000079516 ENSRNOT00000092026 |
Tas1r2
|
taste 1 receptor member 2 |
chr1_-_265573117 | 27.11 |
ENSRNOT00000044195
ENSRNOT00000055915 |
LOC100911951
|
Kv channel-interacting protein 2-like |
chr9_-_94601852 | 27.01 |
ENSRNOT00000022485
|
Ngef
|
neuronal guanine nucleotide exchange factor |
chr7_-_29152442 | 26.74 |
ENSRNOT00000079774
|
Mybpc1
|
myosin binding protein C, slow type |
chr10_+_48240330 | 26.69 |
ENSRNOT00000057798
|
Specc1
|
sperm antigen with calponin homology and coiled-coil domains 1 |
chr19_-_1074333 | 26.59 |
ENSRNOT00000017983
ENSRNOT00000086995 |
Cdh5
|
cadherin 5 |
chr15_+_33600102 | 26.49 |
ENSRNOT00000022664
|
Cmtm5
|
CKLF-like MARVEL transmembrane domain containing 5 |
chr14_-_92077088 | 26.40 |
ENSRNOT00000085175
|
Grb10
|
growth factor receptor bound protein 10 |
chr1_-_153740905 | 26.28 |
ENSRNOT00000023239
|
Prss23
|
protease, serine, 23 |
chr10_+_38877422 | 26.15 |
ENSRNOT00000065229
ENSRNOT00000083162 |
Sept8
|
septin 8 |
chr10_-_109729019 | 25.95 |
ENSRNOT00000054959
|
Ppp1r27
|
protein phosphatase 1, regulatory subunit 27 |
chr4_+_78168117 | 25.90 |
ENSRNOT00000010853
|
Atp6v0e2
|
ATPase, H+ transporting V0 subunit e2 |
chr1_-_260992291 | 25.85 |
ENSRNOT00000035415
ENSRNOT00000034758 |
Slit1
|
slit guidance ligand 1 |
chr2_+_11658568 | 25.83 |
ENSRNOT00000076408
ENSRNOT00000076416 ENSRNOT00000076992 ENSRNOT00000075931 ENSRNOT00000076136 ENSRNOT00000076481 ENSRNOT00000076084 ENSRNOT00000076230 ENSRNOT00000076710 ENSRNOT00000076239 |
Mef2c
|
myocyte enhancer factor 2C |
chr7_+_59200918 | 25.56 |
ENSRNOT00000085073
|
Ptprr
|
protein tyrosine phosphatase, receptor type, R |
chr3_-_12944494 | 25.51 |
ENSRNOT00000023172
|
Mvb12b
|
multivesicular body subunit 12B |
chr7_+_77899322 | 25.42 |
ENSRNOT00000006195
|
Fzd6
|
frizzled class receptor 6 |
chr1_+_127802978 | 25.35 |
ENSRNOT00000055877
|
Adamts17
|
ADAM metallopeptidase with thrombospondin type 1 motif, 17 |
chr5_+_140923914 | 25.24 |
ENSRNOT00000020929
|
Heyl
|
hes-related family bHLH transcription factor with YRPW motif-like |
chr17_+_47721977 | 25.15 |
ENSRNOT00000080800
|
LOC100910792
|
amphiphysin-like |
chr8_-_49038169 | 25.11 |
ENSRNOT00000047303
|
Phldb1
|
pleckstrin homology-like domain, family B, member 1 |
chr3_-_123581518 | 24.80 |
ENSRNOT00000047947
|
Gfra4
|
GDNF family receptor alpha 4 |
chr17_+_15924048 | 24.71 |
ENSRNOT00000050696
|
Wnk2
|
WNK lysine deficient protein kinase 2 |
chr10_+_12994683 | 24.63 |
ENSRNOT00000004702
|
Hcfc1r1
|
host cell factor C1 regulator 1 |
chr1_+_266953139 | 24.57 |
ENSRNOT00000054696
|
Neurl1
|
neuralized E3 ubiquitin protein ligase 1 |
chr10_-_88307132 | 24.53 |
ENSRNOT00000040845
|
Jup
|
junction plakoglobin |
chr15_+_48674380 | 24.50 |
ENSRNOT00000018762
|
Fbxo16
|
F-box protein 16 |
chrX_-_111942749 | 24.47 |
ENSRNOT00000087583
|
AABR07040840.1
|
|
chr8_+_116324040 | 24.44 |
ENSRNOT00000081353
|
Hyal2
|
hyaluronoglucosaminidase 2 |
chr10_+_70262361 | 24.40 |
ENSRNOT00000064625
ENSRNOT00000076973 |
Unc45b
|
unc-45 myosin chaperone B |
chr7_-_120027026 | 24.24 |
ENSRNOT00000011215
|
Card10
|
caspase recruitment domain family, member 10 |
chr14_+_87312203 | 24.24 |
ENSRNOT00000088032
|
Adcy1
|
adenylate cyclase 1 |
chr16_-_19894591 | 24.04 |
ENSRNOT00000085940
|
Ano8
|
anoctamin 8 |
chr2_-_185168476 | 24.03 |
ENSRNOT00000093447
|
Fam160a1
|
family with sequence similarity 160, member A1 |
chr12_-_17972737 | 24.02 |
ENSRNOT00000001783
|
Fam20c
|
FAM20C, golgi associated secretory pathway kinase |
chr3_-_105279462 | 23.98 |
ENSRNOT00000010679
|
Scg5
|
secretogranin V |
chr11_+_16826399 | 23.95 |
ENSRNOT00000050701
|
Cxadr
|
coxsackie virus and adenovirus receptor |
chr10_+_71159869 | 23.84 |
ENSRNOT00000075977
ENSRNOT00000047427 |
Hnf1b
|
HNF1 homeobox B |
chr1_+_72889270 | 23.79 |
ENSRNOT00000058843
ENSRNOT00000034957 |
Tnnt1
|
troponin T1, slow skeletal type |
chr2_-_229718659 | 23.73 |
ENSRNOT00000012676
|
Ugt8
|
UDP glycosyltransferase 8 |
chrX_-_157286936 | 23.70 |
ENSRNOT00000078100
|
Atp2b3
|
ATPase plasma membrane Ca2+ transporting 3 |
chr6_-_50846965 | 23.67 |
ENSRNOT00000087300
|
Slc26a4
|
solute carrier family 26 member 4 |
chr16_-_22561496 | 23.66 |
ENSRNOT00000016543
|
Lpl
|
lipoprotein lipase |
chr9_+_9961021 | 23.66 |
ENSRNOT00000075767
|
Tubb4a
|
tubulin, beta 4A class IVa |
chr6_+_3657325 | 23.66 |
ENSRNOT00000010927
|
Tmem178a
|
transmembrane protein 178A |
chr19_-_43596801 | 23.46 |
ENSRNOT00000025625
|
Fa2h
|
fatty acid 2-hydroxylase |
chr19_+_784618 | 23.33 |
ENSRNOT00000014749
|
Cmtm4
|
CKLF-like MARVEL transmembrane domain containing 4 |
chr8_+_111210811 | 23.23 |
ENSRNOT00000011347
|
Amotl2
|
angiomotin like 2 |
chr1_-_242083484 | 23.19 |
ENSRNOT00000065921
|
Tjp2
|
tight junction protein 2 |
chr4_-_52350624 | 23.15 |
ENSRNOT00000060476
|
Tmem229a
|
transmembrane protein 229A |
chr9_-_38196273 | 23.04 |
ENSRNOT00000044452
|
Dst
|
dystonin |
chr14_+_79540235 | 22.87 |
ENSRNOT00000089334
|
Sorcs2
|
sortilin-related VPS10 domain containing receptor 2 |
chr2_-_30246010 | 22.78 |
ENSRNOT00000023900
|
Mccc2
|
methylcrotonoyl-CoA carboxylase 2 |
chr4_-_129619142 | 22.70 |
ENSRNOT00000047453
|
Lmod3
|
leiomodin 3 |
chr16_-_49820235 | 22.68 |
ENSRNOT00000029628
|
Sorbs2
|
sorbin and SH3 domain containing 2 |
chrX_+_18489597 | 22.61 |
ENSRNOT00000059744
|
LOC681355
|
similar to potassium channel tetramerisation domain containing 12b |
chr1_+_79989019 | 22.57 |
ENSRNOT00000020428
|
Dmpk
|
dystrophia myotonica-protein kinase |
chr9_-_45505767 | 22.54 |
ENSRNOT00000033964
|
Lonrf2
|
LON peptidase N-terminal domain and ring finger 2 |
chr6_+_50528823 | 22.53 |
ENSRNOT00000008321
|
Lamb1
|
laminin subunit beta 1 |
chr20_-_47910375 | 22.51 |
ENSRNOT00000000348
|
Sobp
|
sine oculis binding protein homolog |
chr14_+_99529284 | 22.49 |
ENSRNOT00000006897
ENSRNOT00000067134 |
Vstm2a
|
V-set and transmembrane domain containing 2A |
chr10_-_51669297 | 22.47 |
ENSRNOT00000071595
|
Arhgap44
|
Rho GTPase activating protein 44 |
chr16_+_2670618 | 22.46 |
ENSRNOT00000030102
|
Il17rd
|
interleukin 17 receptor D |
chr5_-_21345805 | 22.37 |
ENSRNOT00000081296
ENSRNOT00000007802 |
Car8
|
carbonic anhydrase 8 |
chr11_+_69739384 | 22.29 |
ENSRNOT00000016340
|
Kalrn
|
kalirin, RhoGEF kinase |
chr1_+_265298868 | 22.28 |
ENSRNOT00000023278
|
Dpcd
|
deleted in primary ciliary dyskinesia |
chr7_+_141973553 | 22.08 |
ENSRNOT00000052075
|
Mettl7a
|
methyltransferase like 7A |
chr14_+_66598259 | 21.98 |
ENSRNOT00000049743
|
Kcnip4
|
potassium voltage-gated channel interacting protein 4 |
chr7_+_29435444 | 21.95 |
ENSRNOT00000008613
|
Slc5a8
|
solute carrier family 5 member 8 |
chr7_+_145117951 | 21.80 |
ENSRNOT00000055272
|
Pde1b
|
phosphodiesterase 1B |
chr8_+_128972311 | 21.73 |
ENSRNOT00000025460
|
Myrip
|
myosin VIIA and Rab interacting protein |
chr4_-_82202096 | 21.72 |
ENSRNOT00000081824
|
LOC100912608
|
homeobox protein Hox-A10-like |
chr14_+_63095720 | 21.67 |
ENSRNOT00000006071
|
Ppargc1a
|
PPARG coactivator 1 alpha |
chr5_+_61657507 | 21.61 |
ENSRNOT00000013228
|
Tmod1
|
tropomodulin 1 |
chr10_+_55275411 | 21.59 |
ENSRNOT00000065895
|
Myh10
|
myosin heavy chain 10 |
chr13_+_75111778 | 21.59 |
ENSRNOT00000006924
|
Tp53i3
|
tumor protein p53 inducible protein 3 |
chr2_+_45104305 | 21.57 |
ENSRNOT00000014559
|
Esm1
|
endothelial cell-specific molecule 1 |
chr10_-_47724499 | 21.54 |
ENSRNOT00000085011
|
Rnf112
|
ring finger protein 112 |
chr1_-_219422268 | 21.53 |
ENSRNOT00000025092
|
Carns1
|
carnosine synthase 1 |
chr5_-_40237591 | 21.46 |
ENSRNOT00000011393
|
Fut9
|
fucosyltransferase 9 |
chr10_+_86669233 | 21.45 |
ENSRNOT00000012340
|
Thra
|
thyroid hormone receptor alpha |
chr2_-_46476203 | 21.21 |
ENSRNOT00000015217
|
Ndufs4
|
NADH:ubiquinone oxidoreductase subunit S4 |
chr4_-_64831233 | 21.14 |
ENSRNOT00000079285
|
Dgki
|
diacylglycerol kinase, iota |
chr3_-_72219246 | 20.88 |
ENSRNOT00000009903
|
Smtnl1
|
smoothelin-like 1 |
chrX_-_136807885 | 20.88 |
ENSRNOT00000010325
|
Igsf1
|
immunoglobulin superfamily, member 1 |
chr1_-_165680176 | 20.82 |
ENSRNOT00000025245
ENSRNOT00000082697 |
Plekhb1
|
pleckstrin homology domain containing B1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
25.2 | 226.4 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
18.6 | 92.9 | GO:0002159 | desmosome assembly(GO:0002159) |
15.7 | 62.8 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
15.6 | 46.8 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
14.6 | 43.9 | GO:0021678 | third ventricle development(GO:0021678) |
14.6 | 43.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
14.5 | 58.0 | GO:0031179 | peptide modification(GO:0031179) |
13.4 | 13.4 | GO:1904000 | positive regulation of eating behavior(GO:1904000) |
13.4 | 66.9 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
13.0 | 38.9 | GO:0071529 | cementum mineralization(GO:0071529) |
12.7 | 63.3 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
12.2 | 36.6 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
11.8 | 35.5 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
11.5 | 57.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
11.2 | 33.5 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
11.0 | 33.1 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
10.8 | 21.7 | GO:1904638 | response to resveratrol(GO:1904638) |
10.7 | 53.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
10.4 | 41.5 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
10.3 | 31.0 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
10.3 | 41.1 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
10.2 | 71.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
10.1 | 40.6 | GO:0051944 | peptidyl-cysteine methylation(GO:0018125) positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
10.1 | 40.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
10.0 | 30.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
9.9 | 39.7 | GO:0098886 | modification of dendritic spine(GO:0098886) |
9.7 | 29.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
9.5 | 57.1 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
9.5 | 28.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
9.5 | 123.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
9.4 | 18.9 | GO:0090427 | activation of meiosis(GO:0090427) |
9.2 | 46.1 | GO:0035106 | operant conditioning(GO:0035106) |
9.2 | 27.5 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
8.9 | 107.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
8.9 | 44.4 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
8.8 | 35.1 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
8.6 | 42.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
8.5 | 25.4 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
8.4 | 25.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
8.3 | 16.6 | GO:0032902 | nerve growth factor production(GO:0032902) |
8.3 | 24.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
8.2 | 40.8 | GO:0050828 | regulation of liquid surface tension(GO:0050828) |
8.1 | 97.7 | GO:0071316 | cellular response to nicotine(GO:0071316) |
8.0 | 16.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
8.0 | 24.0 | GO:0097187 | odontoblast differentiation(GO:0071895) dentinogenesis(GO:0097187) |
8.0 | 23.9 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
7.9 | 23.8 | GO:0061228 | mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) |
7.9 | 31.7 | GO:0061107 | seminal vesicle development(GO:0061107) |
7.9 | 23.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
7.9 | 23.7 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
7.8 | 54.7 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
7.6 | 22.8 | GO:0006552 | leucine catabolic process(GO:0006552) |
7.5 | 22.5 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
7.3 | 73.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
7.2 | 14.4 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
7.2 | 28.6 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
7.2 | 21.5 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
7.1 | 28.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
7.1 | 21.2 | GO:0044209 | AMP salvage(GO:0044209) |
7.0 | 28.1 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
7.0 | 27.9 | GO:1901423 | response to benzene(GO:1901423) |
6.7 | 6.7 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
6.6 | 19.8 | GO:0015938 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) fatty-acyl-CoA catabolic process(GO:0036115) |
6.5 | 25.8 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
6.3 | 31.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
6.3 | 18.8 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
6.1 | 42.9 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
6.0 | 18.1 | GO:0021564 | vagus nerve development(GO:0021564) |
5.9 | 17.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
5.8 | 17.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
5.8 | 11.5 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
5.5 | 27.3 | GO:0001582 | detection of chemical stimulus involved in sensory perception of sweet taste(GO:0001582) |
5.4 | 10.8 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
5.4 | 21.6 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
5.4 | 69.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
5.3 | 15.8 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
5.2 | 15.7 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
5.1 | 25.3 | GO:0046959 | habituation(GO:0046959) |
5.0 | 30.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
5.0 | 14.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
5.0 | 14.9 | GO:0071691 | cardiac muscle thin filament assembly(GO:0071691) |
4.9 | 24.4 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
4.9 | 34.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
4.9 | 14.6 | GO:0070084 | protein initiator methionine removal(GO:0070084) |
4.8 | 4.8 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
4.7 | 75.0 | GO:0021860 | pyramidal neuron development(GO:0021860) |
4.6 | 41.7 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
4.6 | 13.8 | GO:0006116 | NADH oxidation(GO:0006116) |
4.5 | 27.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
4.5 | 22.5 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
4.5 | 49.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
4.4 | 31.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
4.4 | 26.6 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
4.4 | 17.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
4.4 | 17.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
4.4 | 13.1 | GO:0034769 | basement membrane disassembly(GO:0034769) |
4.3 | 42.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
4.3 | 12.8 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
4.3 | 17.1 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
4.2 | 16.8 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
4.1 | 8.3 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
4.1 | 28.8 | GO:0015705 | iodide transport(GO:0015705) |
4.1 | 16.4 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
4.1 | 12.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
4.0 | 16.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
4.0 | 7.9 | GO:0038109 | Kit signaling pathway(GO:0038109) |
3.9 | 19.7 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
3.9 | 23.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
3.9 | 11.7 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
3.8 | 38.5 | GO:0006657 | CDP-choline pathway(GO:0006657) |
3.8 | 19.2 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
3.8 | 26.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
3.7 | 18.7 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
3.7 | 11.2 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
3.7 | 11.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
3.6 | 14.5 | GO:0015888 | thiamine transport(GO:0015888) |
3.6 | 18.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
3.6 | 25.2 | GO:0072014 | proximal tubule development(GO:0072014) |
3.5 | 31.9 | GO:0030953 | astral microtubule organization(GO:0030953) |
3.5 | 10.4 | GO:0015755 | fructose transport(GO:0015755) |
3.4 | 17.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
3.4 | 23.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
3.4 | 23.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
3.4 | 10.1 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
3.3 | 6.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
3.3 | 128.9 | GO:0035640 | exploration behavior(GO:0035640) |
3.2 | 22.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
3.2 | 6.5 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
3.2 | 12.9 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
3.2 | 15.9 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
3.2 | 95.1 | GO:0010107 | potassium ion import(GO:0010107) |
3.1 | 12.6 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
3.1 | 6.2 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
3.1 | 65.0 | GO:0070831 | basement membrane assembly(GO:0070831) |
3.1 | 52.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
3.0 | 12.1 | GO:0001757 | somite specification(GO:0001757) |
3.0 | 111.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
3.0 | 32.9 | GO:0016322 | neuron remodeling(GO:0016322) |
3.0 | 38.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
3.0 | 53.7 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
3.0 | 20.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
3.0 | 14.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
3.0 | 8.9 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
2.9 | 14.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
2.9 | 17.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
2.9 | 41.0 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
2.9 | 5.7 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
2.8 | 76.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
2.8 | 5.6 | GO:0061741 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
2.8 | 11.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
2.8 | 11.2 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
2.8 | 33.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.7 | 32.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
2.7 | 32.6 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
2.7 | 13.4 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
2.6 | 7.9 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
2.6 | 5.3 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
2.6 | 7.9 | GO:0048560 | establishment of anatomical structure orientation(GO:0048560) |
2.6 | 7.8 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
2.6 | 7.7 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
2.6 | 7.7 | GO:0009758 | carbohydrate utilization(GO:0009758) |
2.5 | 12.7 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
2.5 | 19.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
2.4 | 12.1 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
2.4 | 7.2 | GO:2000853 | negative regulation of corticosterone secretion(GO:2000853) |
2.4 | 16.5 | GO:0071000 | response to magnetism(GO:0071000) |
2.3 | 7.0 | GO:1904708 | granulosa cell apoptotic process(GO:1904700) regulation of granulosa cell apoptotic process(GO:1904708) |
2.3 | 18.5 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
2.3 | 9.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
2.3 | 9.2 | GO:0003164 | His-Purkinje system development(GO:0003164) |
2.3 | 4.5 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
2.2 | 20.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
2.2 | 11.1 | GO:0044691 | tooth eruption(GO:0044691) |
2.2 | 12.9 | GO:0032439 | endosome localization(GO:0032439) |
2.2 | 8.6 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) |
2.1 | 4.3 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
2.1 | 8.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
2.1 | 2.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
2.1 | 46.6 | GO:0097503 | sialylation(GO:0097503) |
2.1 | 12.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.1 | 14.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.1 | 12.5 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
2.1 | 35.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
2.1 | 8.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
2.0 | 7.8 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
2.0 | 7.8 | GO:0072070 | loop of Henle development(GO:0072070) |
1.9 | 52.6 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.9 | 23.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
1.9 | 9.6 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
1.9 | 5.7 | GO:1990523 | bone regeneration(GO:1990523) |
1.9 | 13.2 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
1.9 | 15.0 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
1.9 | 20.6 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
1.8 | 7.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.8 | 17.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.8 | 19.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
1.8 | 7.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.8 | 24.6 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
1.7 | 10.5 | GO:0021633 | optic nerve structural organization(GO:0021633) |
1.7 | 67.3 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
1.7 | 6.8 | GO:0007172 | signal complex assembly(GO:0007172) |
1.7 | 28.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.7 | 6.8 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.7 | 8.4 | GO:0032532 | regulation of microvillus length(GO:0032532) |
1.7 | 21.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.6 | 69.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.6 | 6.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
1.6 | 12.5 | GO:0046710 | GDP metabolic process(GO:0046710) |
1.6 | 12.5 | GO:0097688 | glutamate receptor clustering(GO:0097688) |
1.6 | 4.7 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.5 | 15.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
1.5 | 21.5 | GO:0036065 | fucosylation(GO:0036065) |
1.5 | 16.7 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
1.5 | 24.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.5 | 12.1 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
1.5 | 4.5 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
1.5 | 6.0 | GO:0061314 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) Notch signaling involved in heart development(GO:0061314) |
1.5 | 9.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.5 | 9.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.5 | 33.7 | GO:0001553 | luteinization(GO:0001553) |
1.5 | 5.8 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
1.4 | 2.9 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
1.4 | 12.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.4 | 14.1 | GO:0030432 | peristalsis(GO:0030432) |
1.4 | 15.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.4 | 7.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.4 | 12.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.4 | 5.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.4 | 8.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
1.4 | 4.1 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) |
1.4 | 12.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
1.4 | 10.9 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.4 | 5.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
1.3 | 21.4 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
1.3 | 9.3 | GO:0060157 | urinary bladder development(GO:0060157) |
1.3 | 6.5 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
1.3 | 10.4 | GO:0051182 | coenzyme transport(GO:0051182) |
1.3 | 5.2 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.3 | 5.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
1.3 | 30.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
1.3 | 7.5 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
1.2 | 5.0 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
1.2 | 9.9 | GO:1902414 | protein localization to cell junction(GO:1902414) |
1.2 | 19.6 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
1.2 | 19.4 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
1.2 | 3.6 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
1.2 | 19.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
1.2 | 4.8 | GO:0035772 | interleukin-13-mediated signaling pathway(GO:0035772) |
1.2 | 3.6 | GO:0019086 | late viral transcription(GO:0019086) |
1.2 | 7.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
1.2 | 11.6 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
1.2 | 2.3 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
1.1 | 8.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) Golgi disassembly(GO:0090166) |
1.1 | 6.6 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
1.1 | 4.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
1.1 | 3.3 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
1.1 | 5.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
1.1 | 4.4 | GO:1990375 | baculum development(GO:1990375) |
1.1 | 42.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
1.1 | 3.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
1.1 | 16.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
1.1 | 23.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
1.1 | 11.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
1.1 | 1.1 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
1.1 | 16.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
1.0 | 14.6 | GO:0032060 | bleb assembly(GO:0032060) |
1.0 | 14.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.0 | 23.7 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
1.0 | 3.1 | GO:0006574 | valine catabolic process(GO:0006574) |
1.0 | 3.0 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) N-acetylneuraminate biosynthetic process(GO:0046380) glucosamine-containing compound biosynthetic process(GO:1901073) |
1.0 | 36.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.0 | 14.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
1.0 | 12.9 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.0 | 4.0 | GO:0030043 | actin filament fragmentation(GO:0030043) |
1.0 | 8.9 | GO:0000338 | protein deneddylation(GO:0000338) |
1.0 | 6.9 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.0 | 6.9 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
1.0 | 10.5 | GO:0007028 | cytoplasm organization(GO:0007028) |
1.0 | 20.0 | GO:0014002 | astrocyte development(GO:0014002) |
0.9 | 16.0 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.9 | 7.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.9 | 9.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.9 | 8.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.9 | 4.5 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.9 | 3.6 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.9 | 2.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.9 | 32.6 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.9 | 4.4 | GO:2001198 | plasma cell differentiation(GO:0002317) regulation of dendritic cell differentiation(GO:2001198) positive regulation of dendritic cell differentiation(GO:2001200) |
0.9 | 14.8 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.9 | 8.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.8 | 21.2 | GO:0010226 | response to lithium ion(GO:0010226) |
0.8 | 6.8 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.8 | 16.0 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.8 | 5.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.8 | 0.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.8 | 17.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.8 | 5.0 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.8 | 5.8 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.8 | 12.4 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.8 | 4.1 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.8 | 25.9 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
0.8 | 6.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.8 | 12.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.8 | 20.9 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.8 | 6.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.8 | 38.3 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.8 | 10.7 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.8 | 20.6 | GO:0031103 | axon regeneration(GO:0031103) |
0.8 | 4.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.7 | 21.5 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.7 | 22.9 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.7 | 1.5 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.7 | 2.9 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.7 | 11.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.7 | 48.5 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.7 | 1.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.7 | 7.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.7 | 10.6 | GO:0060384 | innervation(GO:0060384) |
0.7 | 36.0 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.7 | 7.0 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.7 | 8.3 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.7 | 15.9 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.7 | 10.3 | GO:0001709 | cell fate determination(GO:0001709) |
0.7 | 15.1 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.7 | 9.6 | GO:0021794 | thalamus development(GO:0021794) |
0.7 | 33.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.7 | 20.4 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.7 | 3.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.7 | 20.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.7 | 16.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.7 | 12.1 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.7 | 6.5 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.6 | 12.2 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.6 | 5.8 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.6 | 3.2 | GO:0033572 | transferrin transport(GO:0033572) |
0.6 | 1.3 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) spinal cord ventral commissure morphogenesis(GO:0021965) |
0.6 | 16.0 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.6 | 7.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.6 | 12.0 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.6 | 56.2 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.6 | 16.6 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.6 | 18.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.6 | 39.1 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.6 | 3.6 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.6 | 12.3 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.6 | 15.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.6 | 5.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.6 | 3.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 3.3 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.5 | 7.0 | GO:0042407 | cristae formation(GO:0042407) |
0.5 | 8.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.5 | 2.0 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.5 | 6.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.5 | 12.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.5 | 14.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.5 | 2.0 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.5 | 6.8 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.5 | 2.9 | GO:0015886 | heme transport(GO:0015886) |
0.5 | 4.3 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.5 | 7.1 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.5 | 10.7 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.5 | 6.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.4 | 13.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.4 | 43.4 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.4 | 6.6 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.4 | 5.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 18.8 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.4 | 6.8 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.4 | 16.8 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.4 | 3.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 17.3 | GO:0007416 | synapse assembly(GO:0007416) |
0.4 | 76.4 | GO:0007517 | muscle organ development(GO:0007517) |
0.4 | 0.4 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.4 | 3.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.4 | 5.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.4 | 6.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.4 | 10.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.4 | 8.3 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.4 | 23.3 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.4 | 5.2 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.4 | 8.9 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.4 | 18.4 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.4 | 21.5 | GO:1901607 | alpha-amino acid biosynthetic process(GO:1901607) |
0.4 | 10.5 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.3 | 5.6 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.3 | 30.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.3 | 2.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 2.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.3 | 7.5 | GO:0001893 | maternal placenta development(GO:0001893) |
0.3 | 1.6 | GO:0021554 | optic nerve development(GO:0021554) |
0.3 | 9.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 4.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.3 | 3.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.3 | 12.8 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.3 | 0.9 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.3 | 4.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.3 | 2.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.3 | 7.7 | GO:0034340 | response to type I interferon(GO:0034340) |
0.3 | 1.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 21.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 6.3 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.3 | 1.3 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.3 | 12.4 | GO:0046677 | response to antibiotic(GO:0046677) |
0.3 | 7.0 | GO:0021762 | substantia nigra development(GO:0021762) |
0.2 | 7.9 | GO:0009409 | response to cold(GO:0009409) |
0.2 | 8.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 10.8 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 4.3 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.2 | 13.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 7.2 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.2 | 1.7 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 4.7 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.2 | 2.5 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.2 | 7.9 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.2 | 3.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 0.4 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 2.3 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.2 | 3.4 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.2 | 10.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 1.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 2.7 | GO:0051893 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) |
0.2 | 0.8 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.9 | GO:2000169 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 7.1 | GO:0001657 | ureteric bud development(GO:0001657) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
0.1 | 2.4 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 19.8 | GO:0006520 | cellular amino acid metabolic process(GO:0006520) |
0.1 | 1.7 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 1.4 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 2.0 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.1 | 0.3 | GO:0055017 | cardiac muscle tissue growth(GO:0055017) |
0.1 | 0.8 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 1.5 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 1.6 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 2.0 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 2.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 3.8 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 1.3 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 4.0 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.1 | 1.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 1.2 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.1 | 1.1 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 3.1 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 1.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.7 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.7 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 1.5 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 50.3 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.4 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.4 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.0 | 88.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
17.3 | 69.3 | GO:0097513 | myosin II filament(GO:0097513) |
16.8 | 50.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
15.7 | 47.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
15.4 | 123.0 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
14.4 | 57.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
13.3 | 53.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
11.7 | 35.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
11.7 | 93.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
11.2 | 44.7 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
10.6 | 63.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
10.2 | 40.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
9.6 | 115.1 | GO:0005861 | troponin complex(GO:0005861) |
9.0 | 63.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
8.6 | 17.2 | GO:0097444 | spine apparatus(GO:0097444) |
7.6 | 38.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
6.8 | 41.0 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
5.7 | 17.1 | GO:0098855 | HCN channel complex(GO:0098855) |
5.6 | 27.9 | GO:0044316 | cone cell pedicle(GO:0044316) |
5.5 | 27.3 | GO:1903767 | sweet taste receptor complex(GO:1903767) taste receptor complex(GO:1903768) |
5.4 | 32.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
5.2 | 98.8 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
5.1 | 25.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
5.1 | 15.2 | GO:0005607 | laminin-2 complex(GO:0005607) |
5.0 | 25.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
4.9 | 38.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
4.8 | 267.2 | GO:0031672 | A band(GO:0031672) |
4.4 | 13.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
4.2 | 12.5 | GO:0098982 | glycine-gated chloride channel complex(GO:0016935) GABA-ergic synapse(GO:0098982) |
4.1 | 20.5 | GO:0071953 | elastic fiber(GO:0071953) |
4.0 | 16.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
4.0 | 15.9 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
3.9 | 23.7 | GO:0033269 | internode region of axon(GO:0033269) |
3.9 | 7.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
3.7 | 11.2 | GO:1990032 | parallel fiber(GO:1990032) |
3.6 | 29.0 | GO:0043203 | axon hillock(GO:0043203) |
3.4 | 20.2 | GO:0008091 | spectrin(GO:0008091) |
3.3 | 63.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
3.1 | 12.6 | GO:0071914 | prominosome(GO:0071914) |
3.1 | 33.7 | GO:0032009 | early phagosome(GO:0032009) |
2.8 | 25.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
2.7 | 8.1 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
2.6 | 15.9 | GO:0044308 | axonal spine(GO:0044308) |
2.5 | 12.7 | GO:0043293 | apoptosome(GO:0043293) |
2.4 | 43.8 | GO:0043196 | varicosity(GO:0043196) |
2.4 | 31.0 | GO:0031045 | dense core granule(GO:0031045) |
2.3 | 11.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
2.0 | 71.7 | GO:0014704 | intercalated disc(GO:0014704) |
2.0 | 32.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
2.0 | 58.9 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
2.0 | 41.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
2.0 | 53.3 | GO:0001533 | cornified envelope(GO:0001533) |
2.0 | 7.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.9 | 60.4 | GO:0097440 | apical dendrite(GO:0097440) |
1.9 | 5.7 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
1.8 | 190.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
1.8 | 31.9 | GO:0034706 | sodium channel complex(GO:0034706) |
1.7 | 46.1 | GO:0042629 | mast cell granule(GO:0042629) |
1.6 | 63.3 | GO:0030315 | T-tubule(GO:0030315) |
1.6 | 40.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.6 | 3.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.5 | 16.7 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
1.5 | 31.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
1.5 | 9.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.5 | 44.6 | GO:0008305 | integrin complex(GO:0008305) |
1.4 | 11.6 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
1.4 | 20.2 | GO:0043194 | axon initial segment(GO:0043194) |
1.4 | 4.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.4 | 5.7 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
1.4 | 268.6 | GO:0030016 | myofibril(GO:0030016) |
1.4 | 8.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.4 | 4.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.4 | 16.4 | GO:0005796 | Golgi lumen(GO:0005796) |
1.3 | 21.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.3 | 5.2 | GO:0018444 | translation release factor complex(GO:0018444) |
1.3 | 45.3 | GO:0005771 | multivesicular body(GO:0005771) |
1.2 | 9.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.2 | 3.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.2 | 18.9 | GO:0030673 | axolemma(GO:0030673) |
1.1 | 8.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.1 | 4.5 | GO:0030478 | actin cap(GO:0030478) |
1.1 | 17.0 | GO:0005883 | neurofilament(GO:0005883) |
1.1 | 5.6 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
1.1 | 22.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.1 | 12.3 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
1.1 | 31.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.1 | 6.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.1 | 7.6 | GO:0045179 | apical cortex(GO:0045179) |
1.0 | 18.1 | GO:0005614 | interstitial matrix(GO:0005614) |
1.0 | 7.0 | GO:0061617 | MICOS complex(GO:0061617) |
1.0 | 18.8 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
1.0 | 22.5 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
1.0 | 2.9 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.9 | 9.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.9 | 10.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.9 | 42.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.9 | 15.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.9 | 11.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.9 | 102.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.9 | 82.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.9 | 33.4 | GO:0045177 | apical part of cell(GO:0045177) |
0.8 | 3.2 | GO:0060091 | kinocilium(GO:0060091) |
0.8 | 22.6 | GO:0005921 | gap junction(GO:0005921) |
0.8 | 5.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.8 | 6.1 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.7 | 115.9 | GO:0043204 | perikaryon(GO:0043204) |
0.7 | 15.6 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.7 | 9.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.7 | 27.1 | GO:0042383 | sarcolemma(GO:0042383) |
0.7 | 7.3 | GO:0034464 | BBSome(GO:0034464) |
0.7 | 10.7 | GO:0045180 | basal cortex(GO:0045180) |
0.7 | 26.1 | GO:0016459 | myosin complex(GO:0016459) |
0.7 | 82.0 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.7 | 21.9 | GO:0032420 | stereocilium(GO:0032420) |
0.7 | 34.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.7 | 36.6 | GO:0031256 | leading edge membrane(GO:0031256) |
0.7 | 2.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.6 | 192.7 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.6 | 4.4 | GO:0090543 | Flemming body(GO:0090543) |
0.6 | 3.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.6 | 12.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.6 | 3.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.5 | 5.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 6.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.5 | 1.6 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.5 | 2.6 | GO:0070695 | FHF complex(GO:0070695) |
0.5 | 46.1 | GO:0030427 | site of polarized growth(GO:0030427) |
0.5 | 21.2 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.5 | 98.5 | GO:0098794 | postsynapse(GO:0098794) |
0.5 | 69.7 | GO:0043209 | myelin sheath(GO:0043209) |
0.5 | 23.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.5 | 8.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 14.5 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.5 | 6.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.5 | 11.0 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.5 | 33.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.5 | 63.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.5 | 27.0 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 6.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 164.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.4 | 12.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 37.9 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.4 | 15.3 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.4 | 5.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 14.0 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.4 | 10.4 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.3 | 76.0 | GO:0043025 | neuronal cell body(GO:0043025) |
0.3 | 6.0 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 4.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 15.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 5.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 5.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 3.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 17.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 1.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.9 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 30.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.2 | 12.8 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 10.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 1.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 1.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 7.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 0.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 6.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 239.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 30.3 | GO:0030141 | secretory granule(GO:0030141) |
0.2 | 2.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 4.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 3.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 1.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 5.5 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 11.9 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 1.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 21.9 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 6.3 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 19.8 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 41.4 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 248.6 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 1.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 21.7 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 7.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.0 | 88.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
18.9 | 226.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
16.1 | 48.2 | GO:0016403 | dimethylargininase activity(GO:0016403) |
15.2 | 60.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
13.7 | 27.5 | GO:0030172 | troponin C binding(GO:0030172) |
11.7 | 93.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
11.3 | 34.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
11.2 | 33.5 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
11.0 | 33.1 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
10.6 | 31.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
10.1 | 81.1 | GO:0071253 | connexin binding(GO:0071253) |
8.4 | 25.2 | GO:0035939 | microsatellite binding(GO:0035939) |
8.1 | 24.4 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
7.5 | 37.5 | GO:0070052 | collagen V binding(GO:0070052) |
7.4 | 51.7 | GO:0031014 | troponin T binding(GO:0031014) |
7.3 | 65.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
7.2 | 28.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
7.2 | 21.6 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
6.9 | 20.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
6.8 | 27.3 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
6.8 | 20.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
6.7 | 53.7 | GO:0008430 | selenium binding(GO:0008430) |
6.5 | 19.4 | GO:0051425 | PTB domain binding(GO:0051425) |
5.9 | 23.7 | GO:0008489 | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity(GO:0008489) |
5.9 | 17.6 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
5.5 | 253.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
5.5 | 71.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
5.5 | 21.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
5.2 | 25.8 | GO:0048495 | Roundabout binding(GO:0048495) |
5.1 | 66.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
5.1 | 50.8 | GO:0031432 | titin binding(GO:0031432) |
5.0 | 25.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
4.9 | 69.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
4.9 | 38.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
4.8 | 24.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
4.8 | 19.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
4.8 | 14.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
4.6 | 55.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
4.6 | 87.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
4.6 | 64.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
4.3 | 17.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
4.3 | 17.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
4.2 | 37.5 | GO:0070061 | fructose binding(GO:0070061) |
4.2 | 12.5 | GO:0022852 | glycine-gated chloride ion channel activity(GO:0022852) |
4.1 | 56.9 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
4.0 | 16.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
4.0 | 19.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
4.0 | 11.9 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
3.7 | 18.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
3.7 | 33.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
3.6 | 18.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.6 | 21.6 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
3.6 | 21.5 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
3.5 | 31.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
3.5 | 21.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
3.4 | 16.8 | GO:0005111 | type 1 fibroblast growth factor receptor binding(GO:0005105) type 2 fibroblast growth factor receptor binding(GO:0005111) |
3.3 | 10.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
3.2 | 6.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
3.1 | 9.3 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
3.1 | 9.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
3.1 | 21.4 | GO:0034711 | inhibin binding(GO:0034711) |
3.0 | 12.1 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
3.0 | 196.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
3.0 | 42.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
2.9 | 14.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
2.9 | 20.4 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.9 | 17.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.8 | 22.8 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
2.8 | 22.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
2.8 | 5.6 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
2.8 | 8.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
2.8 | 144.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
2.7 | 35.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
2.6 | 7.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
2.6 | 7.8 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
2.6 | 57.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
2.6 | 25.8 | GO:0003680 | AT DNA binding(GO:0003680) |
2.6 | 7.7 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
2.6 | 7.7 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
2.6 | 15.4 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
2.5 | 17.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
2.5 | 17.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.5 | 7.4 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
2.4 | 16.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
2.3 | 9.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.3 | 13.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.2 | 20.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.2 | 22.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
2.2 | 11.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.1 | 38.6 | GO:0043274 | phospholipase binding(GO:0043274) |
2.1 | 8.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
2.1 | 34.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
2.1 | 23.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
2.1 | 38.3 | GO:0048156 | tau protein binding(GO:0048156) |
2.1 | 14.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
2.1 | 10.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
2.1 | 14.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
2.1 | 49.6 | GO:0031489 | myosin V binding(GO:0031489) |
2.0 | 24.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
2.0 | 21.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.9 | 209.1 | GO:0005178 | integrin binding(GO:0005178) |
1.9 | 57.7 | GO:0030552 | cAMP binding(GO:0030552) |
1.9 | 34.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.9 | 11.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.8 | 7.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.8 | 45.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
1.7 | 45.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
1.7 | 91.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.7 | 44.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.7 | 49.5 | GO:0003785 | actin monomer binding(GO:0003785) |
1.7 | 19.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.7 | 8.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.7 | 28.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.6 | 25.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.6 | 8.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.6 | 19.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.6 | 7.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.6 | 14.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.6 | 32.9 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
1.5 | 47.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.5 | 15.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.5 | 9.1 | GO:0017040 | ceramidase activity(GO:0017040) |
1.5 | 12.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.5 | 4.5 | GO:0019807 | aspartoacylase activity(GO:0019807) |
1.5 | 23.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.5 | 19.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.5 | 29.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.5 | 93.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
1.5 | 10.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.4 | 44.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
1.4 | 21.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.4 | 24.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
1.4 | 5.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.4 | 11.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.4 | 4.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.4 | 29.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
1.3 | 26.2 | GO:0008373 | sialyltransferase activity(GO:0008373) |
1.3 | 30.1 | GO:0071949 | FAD binding(GO:0071949) |
1.3 | 46.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
1.3 | 154.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
1.3 | 6.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
1.2 | 13.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.2 | 3.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
1.2 | 11.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.1 | 28.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.1 | 27.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.1 | 32.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
1.1 | 13.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.1 | 9.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.1 | 8.6 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
1.1 | 68.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.1 | 22.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.0 | 22.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.0 | 20.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
1.0 | 82.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
1.0 | 3.0 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
1.0 | 43.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
1.0 | 12.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.0 | 6.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
1.0 | 14.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
1.0 | 7.7 | GO:0030506 | ankyrin binding(GO:0030506) |
1.0 | 9.6 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.9 | 23.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.9 | 2.8 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.9 | 6.4 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.9 | 12.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.9 | 19.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.9 | 7.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.9 | 28.5 | GO:0017022 | myosin binding(GO:0017022) |
0.9 | 28.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.9 | 10.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.9 | 22.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.9 | 28.1 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.8 | 4.1 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
0.8 | 5.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.8 | 3.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.8 | 21.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.8 | 11.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.8 | 3.0 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.7 | 5.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.7 | 11.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.7 | 9.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.7 | 4.4 | GO:0048030 | disaccharide binding(GO:0048030) |
0.7 | 14.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.7 | 7.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.7 | 7.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.7 | 13.5 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.7 | 9.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.7 | 13.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.7 | 3.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.6 | 5.8 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.6 | 18.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.6 | 11.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.6 | 59.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.6 | 8.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.6 | 12.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.6 | 23.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.6 | 9.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.6 | 1.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 9.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.5 | 12.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.5 | 14.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.5 | 3.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.5 | 4.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 11.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.5 | 10.9 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 1.6 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.5 | 3.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.5 | 3.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 10.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 1.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.5 | 4.9 | GO:0019841 | retinol binding(GO:0019841) |
0.5 | 6.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.5 | 1.4 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 6.7 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 3.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.5 | 1.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.5 | 22.3 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.5 | 11.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.4 | 43.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.4 | 21.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.4 | 5.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.4 | 13.3 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.4 | 12.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.4 | 4.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.4 | 13.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.4 | 18.6 | GO:0045182 | translation regulator activity(GO:0045182) |
0.4 | 2.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.4 | 12.6 | GO:0042805 | actinin binding(GO:0042805) |
0.4 | 6.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.4 | 49.5 | GO:0008201 | heparin binding(GO:0008201) |
0.4 | 32.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.4 | 4.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 1.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 1.2 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
0.4 | 1.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 4.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.4 | 29.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 6.2 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.4 | 6.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 17.4 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.3 | 6.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 10.2 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.3 | 8.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 16.7 | GO:0043621 | protein self-association(GO:0043621) |
0.3 | 1.0 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 1.9 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.3 | 2.9 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 5.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 7.3 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 20.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 22.8 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
0.2 | 20.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 9.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 0.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 5.9 | GO:0009055 | electron carrier activity(GO:0009055) |
0.2 | 5.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.2 | 3.2 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.2 | 6.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 15.5 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.2 | 4.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 12.7 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.2 | 2.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 21.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 34.6 | GO:0005543 | phospholipid binding(GO:0005543) |
0.2 | 0.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 2.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 5.5 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 1.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 13.2 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 2.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 44.5 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 24.9 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 1.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 4.6 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 9.1 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 11.4 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 2.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) transmembrane receptor protein kinase activity(GO:0019199) |
0.1 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 17.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 67.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
3.5 | 159.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
3.4 | 92.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
3.2 | 118.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
2.5 | 65.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
2.3 | 39.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
2.3 | 103.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
2.3 | 9.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
2.2 | 37.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
2.2 | 87.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
2.1 | 10.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
2.0 | 22.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
2.0 | 306.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.7 | 53.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.5 | 94.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.5 | 81.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.5 | 10.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.5 | 56.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.5 | 42.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.4 | 63.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
1.3 | 17.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
1.1 | 53.1 | PID BMP PATHWAY | BMP receptor signaling |
1.1 | 27.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.0 | 17.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.0 | 11.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.0 | 49.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
1.0 | 26.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.9 | 215.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.9 | 57.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.9 | 10.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.7 | 27.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.7 | 13.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.7 | 15.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.7 | 21.8 | PID FGF PATHWAY | FGF signaling pathway |
0.7 | 117.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.7 | 19.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 8.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.6 | 30.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 13.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.5 | 9.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 21.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.5 | 5.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 20.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 4.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 4.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.4 | 3.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 11.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 11.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 5.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 6.3 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 4.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 5.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 7.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 3.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 3.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 5.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 341.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
5.1 | 101.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
5.0 | 213.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
4.8 | 177.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
4.7 | 99.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
4.3 | 59.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
4.0 | 93.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
3.8 | 134.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
3.1 | 53.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
3.1 | 40.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
2.9 | 26.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
2.9 | 41.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
2.6 | 47.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
2.6 | 31.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
2.4 | 21.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
2.3 | 30.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.3 | 37.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
2.2 | 65.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
2.2 | 24.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
2.2 | 19.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
2.2 | 173.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
2.1 | 57.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.1 | 19.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
2.1 | 8.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
2.0 | 62.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
2.0 | 50.8 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
1.8 | 16.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.7 | 35.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
1.7 | 16.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
1.7 | 16.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.6 | 18.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.6 | 26.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.6 | 18.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.5 | 33.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.5 | 25.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
1.5 | 16.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
1.5 | 19.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.4 | 25.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.4 | 27.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.4 | 49.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.4 | 24.2 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
1.3 | 21.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.3 | 33.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
1.3 | 23.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.3 | 20.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.3 | 10.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
1.2 | 10.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.2 | 14.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.1 | 7.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.0 | 17.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.0 | 9.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.0 | 8.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.9 | 51.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.9 | 13.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.9 | 33.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.9 | 19.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.9 | 121.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.9 | 15.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.9 | 94.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.9 | 7.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.9 | 7.0 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.8 | 6.7 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.8 | 13.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.8 | 63.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.8 | 30.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.8 | 40.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.8 | 14.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.8 | 7.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.7 | 27.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.7 | 24.0 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.7 | 9.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.7 | 15.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.7 | 9.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.6 | 12.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.6 | 26.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.6 | 7.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.5 | 45.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.5 | 6.4 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.5 | 33.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.5 | 10.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.5 | 11.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.5 | 2.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.4 | 7.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 12.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.4 | 22.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.4 | 7.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 19.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.4 | 8.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 14.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 6.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 5.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 9.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.3 | 21.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.3 | 2.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 5.2 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.3 | 3.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 7.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 11.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 4.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 3.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 5.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 11.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 4.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 7.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 3.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 9.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 1.5 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 2.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |